electro-acupuncture -9.5 3.7 -5.2 1.9 -1.8 1.5 -2.6 2.4 12 sham acupuncture -3.5 3.6 -1.6 1.8 -0.7 1.4 - 14-15 Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
14-15
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
13-14
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
15
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.

Geometry of the network
S1
Describe methods used to explore the geometry of the treatment network under study and potential biases related to it. This should include how the evidence base has been graphically summarized for presentation, and what characteristics were compiled and used to describe the evidence base to readers. 
16
Assessment of Inconsistency
S2
Describe the statistical methods used to evaluate the agreement of direct and indirect evidence in the treatment network(s) studied. Describe efforts taken to address its presence when found.
16
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
15
Additional analyses
16
Describe methods of additional analyses if done, indicating which were pre-specified. This may include, but not be limited to, the following:
• Sensitivity or subgroup analyses;
• Meta-regression analyses;
• Alternative formulations of the treatment network; and
• Use of alternative prior distributions for Bayesian analyses (if applicable).
16
RESULTS †
Study selection 17 Give numbers of studies screened, assessed 14-15 , for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
Figure 1
Presentation of network structure
S3
Provide a network graph of the included studies to enable visualization of the geometry of the treatment network.
Figure 2
Summary of network geometry
S4
Provide a brief overview of characteristics of the treatment network. This may include commentary on the abundance of trials and randomized patients for the different interventions and pairwise comparisons in the network, gaps of evidence in the treatment network, and potential biases reflected by the network structure.
7, Table 1 Study characteristics
18
For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. Table 1 Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment. Table 2 Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: 1) simple summary data for each intervention group, and 2) effect estimates and confidence intervals. Modified approaches may be needed to deal with information from larger networks. Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review. This should also include information regarding whether funding has been received from manufacturers of treatments in the network and/or whether some of the authors are content experts with professional conflicts of interest that could affect use of treatments in the network.
Supplementary
